[Multiple manifestations of intolerance of a combination of anti-inflammatory drugs. Role of phenylbutazone].
D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D001241:Aspirin / Q000009:adverse effects; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D004381:Duodenal Ulcer / Q000139:chemically induced; D004890:Erythema / Q000139:chemically induced; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects; D007565:Jaundice / Q000139:chemically induced; D008875:Middle Aged; D010653:Phenylbutazone / Q000009:adverse effects*; D011696:Purpura, Thrombocytopenic / Q000139:chemically induced
D000893:Anti-Inflammatory Agents; D010653:Phenylbutazone; D001241:Aspirin; D007213:Indomethacin
Manifestations multiples d'intolérance á une association d'anti-inflammatoires. Röle de la phénylbutazone